Diagnosis and Chemotherapy of Human Trypanosomiasis and Vector Ecology of Rift Valley and Congo-Crimean Hemorrhagic Fever in Kenya.

Abstract

Careful collection of data from a mouse model, a Kenya Trypanosomiasis Research Institute (KETRI) vervet monkey model, and patients of the Alupe Human Sleeping Sickness Referral Hospital at Busia, Kenya, screening of Walter Reed Army Institute of Research (WRAIR) trypanocides with known therapeutic effects and potential for treatment of African Trypanosomal disease were undertaken. Clinical trials for efficacy of individual drugs regiments for treatment of human trypanosomiasis with acute febrile attacks and chronic, central nervous system involvement in Kenya, and application of an ELISA antigen detection for early determination of efficacy in treatment of human sleeping sickness were assessed. RA I, Volunteers, Hemorrhagic Fever, Vectors, Trypanosomiasis, Rift Valley Fever, Lab Animals, Monkey

Open PDF

Document Details

Document Type
Technical Report
Publication Date
Jan 27, 1994
Accession Number
ADA280198

Entities

People

  • J. K. Omuse

Tags

Communities of Interest

  • Biomedical

DTIC Thesaurus Topics

  • Artificial Satellites
  • Cells
  • Detection
  • Disease Outbreaks
  • Diseases And Disorders
  • Domestic Animals
  • Habitats
  • Health Services
  • Infectious Diseases
  • Medical Personnel
  • Rift Valley Fever
  • Therapy
  • Ticks
  • Virus Diseases
  • Viruses

Fields of Study

  • Medicine

Readers

  • Infectious Disease/Epidemiology
  • Parasitology and Pharmacology of Malaria.
  • Virology (or Medical Virology).